Selected research
Industry Research
AI Pharmaceutical Industry Research Report 2026
Market perspective
The global AI Pharmaceutical market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the AI Pharmaceutical market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the AI Pharmaceutical market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the AI Pharmaceutical market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of AI Pharmaceutical include Noetik, Atomwise, Cradle, Exscientia, Iktos, Insilico Medicine, BenevolentAI, Cyclica and Recursion, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global AI Pharmaceutical market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to AI Pharmaceutical.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
AI Pharmaceutical Market by Company
Noetik
Atomwise
Cradle
Exscientia
Iktos
Insilico Medicine
BenevolentAI
Cyclica
Recursion
Auransa
InveniAI
Pfizer
IBM
AI Pharmaceutical Segment by Type
Artificial intelligence (AI)
Machine Learning (ML)
Others
AI Pharmaceutical Segment by Application
Drug Discovery
Clinical Trials
Others
AI Pharmaceutical Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Pharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of AI Pharmaceutical companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Artificial intelligence (AI)
- Machine Learning (ML)
- Others
Applications
- Drug Discovery
- Clinical Trials
- Others
Companies covered
- Noetik
- Atomwise
- Cradle
- Exscientia
- Iktos
- Insilico Medicine
- BenevolentAI
- Cyclica
- Recursion
- Auransa
- InveniAI
- Pfizer
- IBM
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 AI Pharmaceutical by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Artificial intelligence (AI)
- 2.2.3 Machine Learning (ML)
- 2.2.4 Others
- 2.3 AI Pharmaceutical by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drug Discovery
- 2.3.3 Clinical Trials
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 AI Pharmaceutical Breakdown Data by Type
- 3.1 Global AI Pharmaceutical Historic Market Size by Type (2021-2026)
- 3.2 Global AI Pharmaceutical Forecasted Market Size by Type (2027-2032)
4 AI Pharmaceutical Breakdown Data by Application
- 4.1 Global AI Pharmaceutical Historic Market Size by Application (2021-2026)
- 4.2 Global AI Pharmaceutical Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global AI Pharmaceutical Market Perspective (2021-2032)
- 5.2 Global AI Pharmaceutical Growth Trends by Region
- 5.2.1 Global AI Pharmaceutical Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 AI Pharmaceutical Historic Market Size by Region (2021-2026)
- 5.2.3 AI Pharmaceutical Forecasted Market Size by Region (2027-2032)
- 5.3 AI Pharmaceutical Market Dynamics
- 5.3.1 AI Pharmaceutical Industry Trends
- 5.3.2 AI Pharmaceutical Market Drivers
- 5.3.3 AI Pharmaceutical Market Challenges
- 5.3.4 AI Pharmaceutical Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top AI Pharmaceutical Players by Revenue
- 6.1.1 Global Top AI Pharmaceutical Players by Revenue (2021-2026)
- 6.1.2 Global AI Pharmaceutical Revenue Market Share by Players (2021-2026)
- 6.2 Global AI Pharmaceutical Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of AI Pharmaceutical Head Office and Area Served
- 6.4 Global AI Pharmaceutical Players, Product Type & Application
- 6.5 Global AI Pharmaceutical Manufacturers Established Date
- 6.6 Global AI Pharmaceutical Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America AI Pharmaceutical Market Size (2021-2032)
- 7.2 North America AI Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America AI Pharmaceutical Market Size by Country (2021-2026)
- 7.4 North America AI Pharmaceutical Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe AI Pharmaceutical Market Size (2021-2032)
- 8.2 Europe AI Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe AI Pharmaceutical Market Size by Country (2021-2026)
- 8.4 Europe AI Pharmaceutical Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific AI Pharmaceutical Market Size (2021-2032)
- 9.2 Asia-Pacific AI Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific AI Pharmaceutical Market Size by Country (2021-2026)
- 9.4 Asia-Pacific AI Pharmaceutical Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America AI Pharmaceutical Market Size (2021-2032)
- 10.2 South America AI Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America AI Pharmaceutical Market Size by Country (2021-2026)
- 10.4 South America AI Pharmaceutical Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa AI Pharmaceutical Market Size (2021-2032)
- 11.2 Middle East & Africa AI Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa AI Pharmaceutical Market Size by Country (2021-2026)
- 11.4 Middle East & Africa AI Pharmaceutical Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Noetik
- 12.1.1 Noetik Company Information
- 12.1.2 Noetik Business Overview
- 12.1.3 Noetik Revenue in AI Pharmaceutical Business (2021-2026)
- 12.1.4 Noetik AI Pharmaceutical Product Portfolio
- 12.1.5 Noetik Recent Developments
- 12.2 Atomwise
- 12.2.1 Atomwise Company Information
- 12.2.2 Atomwise Business Overview
- 12.2.3 Atomwise Revenue in AI Pharmaceutical Business (2021-2026)
- 12.2.4 Atomwise AI Pharmaceutical Product Portfolio
- 12.2.5 Atomwise Recent Developments
- 12.3 Cradle
- 12.3.1 Cradle Company Information
- 12.3.2 Cradle Business Overview
- 12.3.3 Cradle Revenue in AI Pharmaceutical Business (2021-2026)
- 12.3.4 Cradle AI Pharmaceutical Product Portfolio
- 12.3.5 Cradle Recent Developments
- 12.4 Exscientia
- 12.4.1 Exscientia Company Information
- 12.4.2 Exscientia Business Overview
- 12.4.3 Exscientia Revenue in AI Pharmaceutical Business (2021-2026)
- 12.4.4 Exscientia AI Pharmaceutical Product Portfolio
- 12.4.5 Exscientia Recent Developments
- 12.5 Iktos
- 12.5.1 Iktos Company Information
- 12.5.2 Iktos Business Overview
- 12.5.3 Iktos Revenue in AI Pharmaceutical Business (2021-2026)
- 12.5.4 Iktos AI Pharmaceutical Product Portfolio
- 12.5.5 Iktos Recent Developments
- 12.6 Insilico Medicine
- 12.6.1 Insilico Medicine Company Information
- 12.6.2 Insilico Medicine Business Overview
- 12.6.3 Insilico Medicine Revenue in AI Pharmaceutical Business (2021-2026)
- 12.6.4 Insilico Medicine AI Pharmaceutical Product Portfolio
- 12.6.5 Insilico Medicine Recent Developments
- 12.7 BenevolentAI
- 12.7.1 BenevolentAI Company Information
- 12.7.2 BenevolentAI Business Overview
- 12.7.3 BenevolentAI Revenue in AI Pharmaceutical Business (2021-2026)
- 12.7.4 BenevolentAI AI Pharmaceutical Product Portfolio
- 12.7.5 BenevolentAI Recent Developments
- 12.8 Cyclica
- 12.8.1 Cyclica Company Information
- 12.8.2 Cyclica Business Overview
- 12.8.3 Cyclica Revenue in AI Pharmaceutical Business (2021-2026)
- 12.8.4 Cyclica AI Pharmaceutical Product Portfolio
- 12.8.5 Cyclica Recent Developments
- 12.9 Recursion
- 12.9.1 Recursion Company Information
- 12.9.2 Recursion Business Overview
- 12.9.3 Recursion Revenue in AI Pharmaceutical Business (2021-2026)
- 12.9.4 Recursion AI Pharmaceutical Product Portfolio
- 12.9.5 Recursion Recent Developments
- 12.10 Auransa
- 12.10.1 Auransa Company Information
- 12.10.2 Auransa Business Overview
- 12.10.3 Auransa Revenue in AI Pharmaceutical Business (2021-2026)
- 12.10.4 Auransa AI Pharmaceutical Product Portfolio
- 12.10.5 Auransa Recent Developments
- 12.11 InveniAI
- 12.11.1 InveniAI Company Information
- 12.11.2 InveniAI Business Overview
- 12.11.3 InveniAI Revenue in AI Pharmaceutical Business (2021-2026)
- 12.11.4 InveniAI AI Pharmaceutical Product Portfolio
- 12.11.5 InveniAI Recent Developments
- 12.12 Pfizer
- 12.12.1 Pfizer Company Information
- 12.12.2 Pfizer Business Overview
- 12.12.3 Pfizer Revenue in AI Pharmaceutical Business (2021-2026)
- 12.12.4 Pfizer AI Pharmaceutical Product Portfolio
- 12.12.5 Pfizer Recent Developments
- 12.13 IBM
- 12.13.1 IBM Company Information
- 12.13.2 IBM Business Overview
- 12.13.3 IBM Revenue in AI Pharmaceutical Business (2021-2026)
- 12.13.4 IBM AI Pharmaceutical Product Portfolio
- 12.13.5 IBM Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst